Celon Pharma S.A. (FRA:8RP)

Market Cap	244.69M -28.9%
Revenue (ttm)	52.87M +7.3%
Net Income	-28.68M
EPS	-0.55
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	6
Open	4.400
Previous Close	4.850
Day's Range	4.400 - 4.400
52-Week Range	4.265 - 6.570
Beta	n/a
RSI	43.68
Earnings Date	Apr 22, 2026

About Celon Pharma

Celon Pharma S.A., an integrated pharmaceutical company, engages in the research, manufacture, and marketing of pharmaceutical products and preparations. It offers drugs to treat cancers, neurological diseases, diabetes, and other metabolic disorders. The company was founded in 2002 and is based in Lomianki, Poland. Celon Pharma S.A. operates as a subsidiary of Glatton Sp. z o.o.

• Industry: Pharmaceutical Preparations
• Founded: 2002
• Employees: 566
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 8RP

Financial Performance

In 2024, Celon Pharma's revenue was 205.55 million, a decrease of -4.25% compared to the previous year's 214.66 million. Losses were -34.45 million, 22.5% more than in 2023.

Financial numbers in PLN